Sirio Pharma (300791) — Free Cash Flow Generation Index
Sirio Pharma (300791) has a Free Cash Flow Generation Index of 0.41x as of June 2023. Free cash flow of CN¥41.96 Million represents 0% of operating cash flow (CN¥101.61 Million). See working capital to net assets of Sirio Pharma to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sirio Pharma Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Sirio Pharma across 8 annual periods. Explore Sirio Pharma cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sirio Pharma (2017–2024)
Year-by-year Free Cash Flow Generation Index for Sirio Pharma. For the full company profile including market capitalisation, see Sirio Pharma market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥154.84 Million | CN¥566.97 Million | CN¥412.13 Million | ▲ +260.7% |
| 2023 | -0.17x | CN¥-65.62 Million | CN¥386.08 Million | CN¥451.70 Million | ▼ -150.0% |
| 2022 | 0.34x | CN¥151.17 Million | CN¥444.86 Million | CN¥293.69 Million | ▲ +163.3% |
| 2021 | -0.54x | CN¥-183.31 Million | CN¥341.38 Million | CN¥524.68 Million | ▼ -278.0% |
| 2020 | 0.30x | CN¥96.43 Million | CN¥319.57 Million | CN¥223.14 Million | ▲ +8.0% |
| 2019 | 0.28x | CN¥64.71 Million | CN¥231.60 Million | CN¥166.90 Million | ▲ +191.7% |
| 2018 | -0.30x | CN¥-55.87 Million | CN¥183.46 Million | CN¥239.32 Million | ▲ +86.4% |
| 2017 | -2.24x | CN¥-110.47 Million | CN¥49.35 Million | CN¥159.82 Million | — |